Alvimopan Capsule
Product Images NDC 51407-870

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Alvimopan (NDC 51407-870). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-870-33cb (Carton -PL)

51407-870-33cb (Carton -PL)
Packaging label for Alvimopan 12 mg capsules, a human prescription drug in oral capsule form. The label indicates a package size of 30 (5x6) unit-dose capsules. The labeler is Golden State Medical Supply, Inc., with the product NDC 51407-870. The label states "Rx only" and "Hospital Use Only." Storage instructions and manufacturer information (Hikma Pharmaceuticals USA Inc.) are included.*
FDA Label Image

Chemical Structure (Alvimopan 01)

Chemical Structure (Alvimopan 01)
Chemical structure of Alvimopan dihydrate, showing its molecular arrangement with indicated hydration (2H2O). The diagram includes the phenyl rings, hydroxyl groups, amide bonds, and other structural features characteristic of Alvimopan.*
FDA Label Image

Figure 1 (Alvimopan 02)

Figure 1 (Alvimopan 02)
A Kaplan-Meier curve chart showing the estimated probability of achieving an endpoint over time in hours after surgery. The chart compares Alvimopan (dashed line) with Placebo (solid line), plotting survival probabilities on the vertical axis and hours after surgery on the horizontal axis, indicating the time course of achieving the endpoint for both groups.*
FDA Label Image

Figure 2 (Alvimopan 03)

Figure 2 (Alvimopan 03)
A line graph comparing the estimated probability of achieving an endpoint over time (hours after end of surgery) for Alvimopan and placebo groups. The Y-axis represents the probability from 0.0 to 1.0, and the X-axis shows time up to 264 hours. Alvimopan is shown with a dashed line, reaching higher probabilities earlier than the solid line representing placebo.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.